- Vaccinees who meet all of the following conditions at the time of the first
vaccination among infants who use Prevenar 13 in accordance with the indication, and
dosage and administration of the vaccine will be included in the investigation:
- Infants aged 2 months, inclusive, to 7 months, exclusive
- Infants with no history of administration of pneumococcal vaccines including Prevenar
13
- Infants expected to receive 4 vaccinations
- Vaccines must not be performed if the vaccinee corresponds to any of the following:
- Persons in whom a past history of anaphylaxis due to an ingredient of Prevenar 13 or
diphtheria toxoid is evident
- Persons with evident pyrexia
- Persons who evidently have serious acute diseases
- Besides the persons listed above, persons who are in a status inappropriate for
immunization